Intensity-modulated radiotherapy for locally advanced cancers of the larynx and hypopharynx
โ Scribed by Megan E. Daly; Quynh-Thu Le; Anshu K. Jain; Peter G. Maxim; Annie Hsu; Billy W. Loo Jr; Michael J. Kaplan; Nancy J. Fischbein; A. Dimitrios Colevas; Harlan Pinto; Daniel T. Chang
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 231 KB
- Volume
- 33
- Category
- Article
- ISSN
- 1043-3074
No coin nor oath required. For personal study only.
โฆ Synopsis
Abstract
Background
Limited data evaluate intensityโmodulated radiotherapy (IMRT) for cancers of the hypopharynx and larynx. We report clinical outcomes and failure patterns for these patients.
Methods
Between September 2001 and December 2007, 42 patients with squamous cell carcinoma (SCC) of the hypopharynx (n = 23) and larynx (n = 19) underwent IMRT, 11 postoperatively and 31 definitively. Thirtyโsix received systemic therapy. Median followโup was 30 months among surviving patients.
Results
Three local failures occurred within the highโdose region and 3 occurred in regional nodes. Seven patients developed distant metastasis as the initial failure. Threeโyear actuarial estimates of locoregional control, freedom from distant metastasis, and overall survival rates were, respectively, 80%, 72%, and 46%.
Conclusions
IMRT provides good locoregional control for SCC of the hypopharynx and larynx compared with historical controls. Locoregional relapses occurred in the highโdose volumes, suggesting adequate target volume delineation. Hypopharyngeal tumors, which fare worse than laryngeal tumors, warrant investigation of more aggressive treatment. ยฉ 2010 Wiley Periodicals, Inc. Head Neck, 2011
๐ SIMILAR VOLUMES
## Abstract ## Background We present outcome data from concurrent chemotherapy and intensityโmodulated radiation therapy (IMRT) for squamous cell carcinoma (SCC) of the larynx and oropharyx. ## Methods Eighty patients with laryngeal (__n__ = 15) or oropharyngeal (__n__ = 65) SCC underwent concur
## Abstract ## Background Angiosarcoma arising after radiation is described in breast cancer but occurs elsewhere. Here, we present an angiosarcoma of the neck occurring after curative chemoradiation. ## Methods This is a case of angiosarcoma developing 5 years after curative therapy for T3N0 sq